Article Details
Retrieved on: 2022-07-11 16:12:47
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Finally, Neo Ivy Capital Management bought a new position in shares of Sarepta Therapeutics during the 4th quarter worth about $405,000.
Article found on: www.defenseworld.net
This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here